Moderna, Inc.
KZ ˙ KAS ˙ US60770K1079
54,85 $ 0,00 (0,00%)
2026-04-22
DEL PRIS
SecurityKZ:MRNA_KZ / Moderna, Inc.
InstitutionBLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A
Latest Disclosed Ownership88,661 shares
Latest Disclosed Value $ 2,620,819
BLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A ownership in MRNA_KZ / Moderna, Inc.

On September 26, 2025 - BLACKROCK GLOBAL ALLOCATION FUND, INC. - BLACKROCK GLOBAL ALLOCATION FUND, INC. Investor A filed a NPORT-P form disclosing ownership of 88,661 shares of Moderna, Inc. (KZ:MRNA_KZ) valued at $2,620,819 USD as of July 31, 2025. The entity filed a previous NPORT-P on June 26, 2025 disclosing 0 shares of Moderna, Inc.. The current value of the position is $4,863,056 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-09-26 2025-07-31 NP Moderna EC US60770K1079 88,661 88,661 2,621 0.0159
2025-06-26 2025-04-30 NP Moderna EC US60770K1079 0 -171,011 -100.00 0 -100.00
2025-03-27 2025-01-31 NP Moderna EC US60770K1079 171,011 133,260 353.00 6,741 228.51 0.0408
2024-12-26 2024-10-31 NP Moderna EC US60770K1079 37,751 12,567 49.90 2,052 -31.65 0.0123
2024-09-27 2024-07-31 NP Moderna EC US60770K1079 25,184 5,119 25.51 3,002 35.65 0.0174
2024-06-27 2024-04-30 NP Moderna EC US60770K1079 20,065 20,065 2,213 0.0131
2024-03-27 2024-01-31 NP Moderna EC US60770K1079 0 -24,505 -100.00 0 -100.00
2023-12-27 2023-10-31 NP Moderna EC US60770K1079 24,505 -3,566 -12.70 1,861 -43.64 0.0114
2023-09-26 2023-07-31 NP Moderna EC US60770K1079 28,071 23,267 484.33 3,303 417.55 0.0180
2023-06-27 2023-04-30 NP Moderna EC US60770K1079 4,804 4,804 638 0.0035
2022-09-27 2022-07-31 NP Moderna EC US60770K1079 0 -38,915 -100.00 0 -100.00
2022-06-27 2022-04-30 NP Moderna EC US60770K1079 38,915 -26,071 -40.12 5,231 -52.47 0.0238
2022-03-29 2022-01-31 NP Moderna EC US60770K1079 64,986 -31,858 -32.90 11,004 -67.08 0.0445
2021-12-28 2021-10-31 NP Moderna EC US60770K1079 96,844 63,402 189.59 33,432 182.71 0.1244
2021-09-28 2021-07-31 NP Moderna EC US60770K1079 33,442 33,442 11,825 0.0435
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.